Company Intelligence

Spect

Vision Disease cause innumerable cases of preventable blindness globally - 415 million diabetic patients worldwide are susceptible to Diabetic Retinopathy (DR), Glaucoma, and more. Current screening protocols for vision disease require ophthalmologists to manually diagnose patients…

In this profile

Quick Facts

  • Founded 2017
  • Headquarters San Francisco, USA; Remote
  • Country USA; Remote
  • Industry AI in Healthcare
  • Company Type Early
  • Status Inactive
  • Website Official site
  • Last Reviewed Jul 2026

Executive Summary

Vision Disease cause innumerable cases of preventable blindness globally - 415 million diabetic patients worldwide are susceptible to Diabetic Retinopathy (DR), Glaucoma, and more. Current screening protocols for vision disease require ophthalmologists to manually diagnose patients through visual assessment of the fundus. Given the large number of diabetes patients in various communities, this process is expensive, inefficient, and an undue burden on eye clinics.

Why It Matters

Value-based retinal screening in primary care to prevent blindness.

Recent Developments

  1. 2017 Company founded

    Spect was founded in 2017 per the company profile source on file.

    Source

Connected Reports

Connected Insights

Industries

Vision Disease cause innumerable cases of preventable blindness globally – 415 million diabetic patients worldwide are susceptible to Diabetic Retinopathy (DR), Glaucoma, and more. Current screening protocols for vision disease require ophthalmologists to manually diagnose patients through visual assessment of the fundus. Given the large number of diabetes patients in various communities, this process is expensive, inefficient, and an undue burden on eye clinics.

Company information is based on publicly available sources and is reviewed periodically. If you represent this company and would like to request a correction, contact Brel.

Explore Related Intelligence

The AI Brief

Weekly company intelligence in your inbox.

Subscribe